Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation

[1]  Liang Zhao,et al.  Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1 , 2019, Journal of Experimental & Clinical Cancer Research.

[2]  Yan Zhao,et al.  Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis , 2019, Journal of Hematology & Oncology.

[3]  Min You,et al.  Adipose-Derived Mesenchymal Stem Cells Enhance Ovarian Cancer Growth and Metastasis by Increasing Thymosin Beta 4X-Linked Expression , 2019, Stem cells international.

[4]  Xuehao Wang,et al.  Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities , 2019, Molecular Cancer.

[5]  W. Świȩszkowski,et al.  Mechano-signalling, induced by fullerene C60 nanofilms, arrests the cell cycle in the G2/M phase and decreases proliferation of liver cancer cells , 2019, International journal of nanomedicine.

[6]  M. Buti,et al.  The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B , 2017, Hepatology.

[7]  Tao Zhang,et al.  Effect of matrix stiffness on osteoblast functionalization , 2017, Cell proliferation.

[8]  Tzong-Ming Shieh,et al.  Lysyl Oxidase and the Tumor Microenvironment , 2016, International journal of molecular sciences.

[9]  Xuetao Cao,et al.  Characteristics and Significance of the Pre-metastatic Niche. , 2016, Cancer cell.

[10]  Tao Zhang,et al.  Softening Substrates Promote Chondrocytes Phenotype via RhoA/ROCK Pathway. , 2016, ACS applied materials & interfaces.

[11]  Xuetao Cao,et al.  Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. , 2016, Cancer cell.

[12]  X. Mao,et al.  Role of nuclear Met-derived exosomes in hepatocellular carcinoma metastasis and lung premetastatic niche formation , 2016 .

[13]  M. Yashiro,et al.  Lysyl oxidase is associated with the epithelial–mesenchymal transition of gastric cancer cells in hypoxia , 2016, Gastric Cancer.

[14]  A. Papavassiliou,et al.  Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2–NF-κB and JNK–AP-1 signaling pathways , 2016, Cellular and Molecular Life Sciences.

[15]  Z. Ren,et al.  Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells , 2016, Oncotarget.

[16]  V. Weaver,et al.  Loss of miR-203 regulates cell shape and matrix adhesion through ROBO1/Rac/FAK in response to stiffness , 2016, The Journal of cell biology.

[17]  J. Erler,et al.  Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis. , 2016, Cancer research.

[18]  Z. Ren,et al.  Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway , 2015, PloS one.

[19]  Xiao-Jun Ma,et al.  Role of three‐dimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cells , 2015, Biotechnology and applied biochemistry.

[20]  Albert C. Chen,et al.  Matrix stiffness drives Epithelial-Mesenchymal Transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway , 2015, Nature Cell Biology.

[21]  I. Ng,et al.  Lysyl oxidase‐like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma , 2014, Hepatology.

[22]  J. Erler,et al.  Lysyl oxidase in cancer research. , 2014, Future oncology.

[23]  K. Csiszȧr,et al.  Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization , 2014, Oncogene.

[24]  Guanqing Ou,et al.  Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression , 2014, Nature Medicine.

[25]  Z. Ren,et al.  Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1. , 2014, Biochemical and biophysical research communications.

[26]  N. Shinohara,et al.  Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis , 2013, British Journal of Cancer.

[27]  Dennis E. Discher,et al.  Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation , 2013, Science.

[28]  A. Möller,et al.  The pre-metastatic niche: finding common ground , 2013, Cancer and Metastasis Reviews.

[29]  J. Erler,et al.  Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK , 2013, Oncogene.

[30]  D. Lin,et al.  Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma , 2013, Head & neck.

[31]  J. Parsons,et al.  Matrix Rigidity Regulates Cancer Cell Growth by Modulating Cellular Metabolism and Protein Synthesis , 2012, PloS one.

[32]  R. Figlin,et al.  S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. , 2012, Cancer cell.

[33]  Taebo Sim,et al.  Discovery of potent and selective covalent inhibitors of JNK. , 2012, Chemistry & biology.

[34]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation , 2011, Proceedings of the National Academy of Sciences.

[35]  Anirudh Sethi,et al.  Transforming growth factor-beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. , 2011, Investigative ophthalmology & visual science.

[36]  D. Lyden,et al.  The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. , 2011, Seminars in cancer biology.

[37]  Daniel Benten,et al.  Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells , 2011, Hepatology.

[38]  V. Bronte,et al.  Myeloid cell diversification and complexity: an old concept with new turns in oncology , 2011, Cancer and Metastasis Reviews.

[39]  N. Hay,et al.  Deregulation of FoxM1b leads to tumour metastasis , 2011, EMBO molecular medicine.

[40]  Gang Zhao,et al.  Mechanical stiffness of liver tissues in relation to integrin β1 expression may influence the development of hepatic cirrhosis and hepatocellular carcinoma , 2010, Journal of surgical oncology.

[41]  Qian Liu,et al.  Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. , 2009, Carcinogenesis.

[42]  N. Kato,et al.  Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography , 2009, Hepatology.

[43]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[44]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[45]  J. Cardelli,et al.  The β1 Integrin Activates JNK Independent of CagA, and JNK Activation Is Required for Helicobacter pylori CagA+-induced Motility of Gastric Cancer Cells* , 2008, Journal of Biological Chemistry.

[46]  S. Fong,et al.  Lysyl oxidase‐like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors , 2007, Genes, chromosomes & cancer.

[47]  S. Rafii,et al.  Preparing the "soil": the premetastatic niche. , 2006, Cancer research.

[48]  Kenneth M. Yamada,et al.  The matrix reorganized: extracellular matrix remodeling and integrin signaling. , 2006, Current opinion in cell biology.

[49]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[50]  K. Csiszȧr,et al.  A molecular role for lysyl oxidase‐like 2 enzyme in Snail regulation and tumor progression , 2005, The EMBO journal.

[51]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[52]  M. Neeman,et al.  Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. , 2003, Cancer research.

[53]  Kenneth M. Yamada,et al.  Fibronectin at a glance , 2002, Journal of Cell Science.

[54]  M. Hendrix,et al.  A molecular role for lysyl oxidase in breast cancer invasion. , 2002, Cancer research.

[55]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[56]  E. D. Harris.  Copper-induced activation of aortic lysyl oxidase in vivo. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Fadlo R Khuri,et al.  Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. , 2006, Cancer research.

[58]  P. Gallop,et al.  Cross-linking in collagen and elastin. , 1984, Annual review of biochemistry.